Processa Pharmaceuticals (PCSA) director Sheila Gujrathi files initial Form 3 ownership

Rhea-AI Filing Summary

Processa Pharmaceuticals, Inc. director Sheila Gujrathi has submitted an initial Form 3 insider ownership report. The statement does not list any reportable holdings of Processa Pharmaceuticals securities or derivative instruments for her and shows no insider transactions at the time covered.

Key Terms

beneficial ownership, reporting person, Form 3

3 terms

beneficial ownership regulatory

"Initial statement of beneficial ownership of securities for a company insider"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"Identifies the reporting person responsible for disclosing insider holdings"

Form 3 regulatory

"SEC Form 3 serves as an initial statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/30/2026 - 09:46 PM Accepted by SEC EDGAR 07/30/2026 - 09:46 PM Learn about SEC filing dates

FAQ

What does the Processa Pharmaceuticals (PCSA) Form 3 filed for Sheila Gujrathi show?

The Form 3 for Sheila Gujrathi, a director of Processa Pharmaceuticals (PCSA), reports no beneficial ownership of company securities and no derivative positions. It also indicates there were no insider transactions to disclose as of the reporting date.

Who is the reporting person in the Processa Pharmaceuticals (PCSA) Form 3?

The reporting person is Sheila Gujrathi, who serves as a director of Processa Pharmaceuticals, Inc. The Form 3 identifies her role as a director and provides her initial statement of beneficial ownership regarding PCSA securities.

Does Sheila Gujrathi report any Processa Pharmaceuticals (PCSA) share ownership on this Form 3?

No. The Form 3 for Sheila Gujrathi does not list any reportable holdings of Processa Pharmaceuticals common stock or derivative securities. It reflects an absence of reported beneficial ownership at the time of this initial filing.

Are there any insider transactions disclosed for PCSA in this Form 3 by Sheila Gujrathi?

No insider transactions are disclosed. The Form 3 shows no purchases, sales, exercises, or gifts of Processa Pharmaceuticals securities by Sheila Gujrathi, indicating zero reportable transaction activity for the covered period.

What is the purpose of the Processa Pharmaceuticals (PCSA) Form 3 related to Sheila Gujrathi?

This Form 3 serves as an initial statement of beneficial ownership for director Sheila Gujrathi at Processa Pharmaceuticals. It establishes her starting position by confirming there are no reportable holdings or derivative securities associated with her at that time.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

GUJRATHI SHEILA

(Last) (First) (Middle)

601 21ST STREET, SUITE 300

(Street)

VERO BEACH FLORIDA 32960

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/28/2026

3. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc. [ PCSA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Sheila Gujrathi	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)